OncoRes Medical Rebrands as Ziva Surgical Ahead of ELORA Launch
Image
PERTH – November 12, 2026 -- OncoRes Medical has rebranded as Ziva Surgical, moving its ELORA System, which holds FDA Breakthrough Device Designation and more than 44 granted patents, closer to commercialization.
Ziva Surgical targets residual cancer found after breast-conserving surgery
The Perth-based tissue intelligence company is addressing a persistent clinical gap: about one in five women undergoing breast-conserving surgery faces a second operation to remove residual cancer. Surgeons currently rely on sight, touch, specimen imaging and clinical judgment, methods that can leave residual cancer undetected during the procedure.